Disruption of old processes by new technologies may be a positive concept and may stimulate innovation; however, we must acknowledge that disruption is not what patients seek, especially when considering their healthcare, their well-being, and their livelihood. Learn why disruption is occurring and the approaches that must be taken to eliminate this disruption for patients and other stakeholders to smooth the path toward better participation in this Applied Clinical Trials article co-authored by Rebecca Kush, Ph.D., scientific innovation officer, and John Potthoff, Ph.D., CEO at Elligo Health Research.

READ MORE.